Advertisement

Infection

, Volume 39, Issue 3, pp 185–199 | Cite as

Costs of hospital-acquired infection and transferability of the estimates: a systematic review

  • H. Fukuda
  • J. Lee
  • Y. ImanakaEmail author
Review

Abstract

Hospital-acquired infections (HAIs) present a substantial problem for healthcare providers, with a relatively high frequency of occurrence and considerable damage caused. There has been an increase in the number of cost-effectiveness and cost-savings analyses of HAI control measures, and the quantification of the cost of HAI (COHAI) is necessary for such calculations. While recent guidelines allow researchers to utilize COHAI estimates from existing published literature when evaluating the economic impact of HAI control measures, it has been observed that the results of economic evaluations may not be directly applied to other jurisdictions due to differences in the context and circumstances in which the original results were produced. The aims of this study were to conduct a systematic review of published studies that have produced COHAI estimates from 1980 to 2006 and to evaluate the quality of these estimates from the perspective of transferability. From a total of 89 publications, only eight papers (9.0%) had a high level of transferability in which all components of costs were described, data for costs in each component were reported, and unit costs were estimated with actual costing. We also did not observe a higher citation level for studies with high levels of transferability. We feel that, in order to ensure an appropriate contribution to the infection control program decision-making process, it is essential for researchers who estimate COHAI, analysts who use COHAI estimates for decision-making, as well as relevant journal reviewers and editors to recognize the importance of a transferability paradigm.

Keywords

Hospital-acquired infection Costs Transferability Costing method 

Notes

Acknowledgments

This work was supported by a Grant-in-Aid for the Japan Society for the Promotion of Science (JSPS) Fellows and a Health Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan.

Conflict of interest

We certify that there is no actual or potential conflict of interest in relation to this article.

References

  1. 1.
    Klevens RM, Edwards JR, Richards CL Jr, Horan TC, Gaynes RP, Pollock DA, et al. Estimating health care-associated infections and deaths in U.S. hospitals, 2002. Public Health Rep. 2007;122:160–6.PubMedGoogle Scholar
  2. 2.
    Perencevich EN, Stone PW, Wright SB, Carmeli Y, Fisman DN, Cosgrove SE. Raising standards while watching the bottom line: making a business case for infection control. Infect Control Hosp Epidemiol. 2007;28:1121–33.PubMedGoogle Scholar
  3. 3.
    Harbarth S, Sax H, Gastmeier P. The preventable proportion of nosocomial infections: an overview of published reports. J Hosp Infect. 2003;54:258–66.PubMedGoogle Scholar
  4. 4.
    Fukuda H, Imanaka Y. Assessment of transparency of cost estimates in economic evaluations of patient safety programmes. J Eval Clin Pract. 2009;15:451–9.PubMedGoogle Scholar
  5. 5.
    Drummond M, Barbieri M, Cook J, Glick HA, Lis J, Malik F, et al. Transferability of economic evaluations across jurisdictions: ISPOR Good Research Practices Task Force report. Value Health. 2009;12:409–18.PubMedGoogle Scholar
  6. 6.
    Sculpher MJ, Pang FS, Manca A, Drummond MF, Golder S, Urdahl H, et al. Generalisability in economic evaluation studies in healthcare: a review and case studies. Health Technol Assess. 2004;8:1–192.Google Scholar
  7. 7.
    Drummond MF, Jefferson TO. Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party. BMJ. 1996;313:275–83.PubMedGoogle Scholar
  8. 8.
    Drummond MF, Sculpher MJ, Torrance GW, O’Brien BJ, Stoddart GL. Methods for the economic evaluation of health care programmes. New York: Oxford University Press; 2005.Google Scholar
  9. 9.
    Gold MR, Siegel JE, Russell LB, Weinstein MC. Cost-effectiveness in health and medicine. New York: Oxford University Press; 1996.Google Scholar
  10. 10.
    Heyland DK, Kernerman P, Gafni A, Cook DJ. Economic evaluations in the critical care literature: do they help us improve the efficiency of our unit? Crit Care Med. 1996;24:1591–8.PubMedGoogle Scholar
  11. 11.
    Shwartz M, Young DW, Siegrist R. The ratio of costs to charges: how good a basis for estimating costs? Inquiry. 1995–1996;32:476–81.Google Scholar
  12. 12.
    Coello R, Glenister H, Fereres J, Bartlett C, Leigh D, Sedgwick J, et al. The cost of infection in surgical patients: a case–control study. J Hosp Infect. 1993;25:239–50.PubMedGoogle Scholar
  13. 13.
    Plowman R, Graves N, Griffin MA, Roberts JA, Swan AV, Cookson B, et al. The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed. J Hosp Infect. 2001;47:198–209.PubMedGoogle Scholar
  14. 14.
    Zoutman D, McDonald S, Vethanayagan D. Total and attributable costs of surgical-wound infections at a Canadian tertiary-care center. Infect Control Hosp Epidemiol. 1998;19:254–9.PubMedGoogle Scholar
  15. 15.
    Boyce JM, Potter-Bynoe G, Dziobek L. Hospital reimbursement patterns among patients with surgical wound infections following open heart surgery. Infect Control Hosp Epidemiol. 1990;11:89–93.PubMedGoogle Scholar
  16. 16.
    Sheng WH, Chie WC, Chen YC, Hung CC, Wang JT, Chang SC. Impact of nosocomial infections on medical costs, hospital stay, and outcome in hospitalized patients. J Formos Med Assoc. 2005;104:318–26.PubMedGoogle Scholar
  17. 17.
    Hollenbeak CS, Alfrey EJ, Souba WW. The effect of surgical site infections on outcomes and resource utilization after liver transplantation. Surgery. 2001;130:388–95.PubMedGoogle Scholar
  18. 18.
    Fabry J, Meynet R, Joron MT, Sepetjan M, Lambert DC, Guillet R. Cost of nosocomial infections: analysis of 512 digestive surgery patients. World J Surg. 1982;6:362–5.PubMedGoogle Scholar
  19. 19.
    Wilson AP, Hodgson B, Liu M, Plummer D, Taylor I, Roberts J, et al. Reduction in wound infection rates by wound surveillance with postdischarge follow-up and feedback. Br J Surg. 2006;93:630–8.PubMedGoogle Scholar
  20. 20.
    Coskun D, Aytac J, Aydinli A, Bayer A. Mortality rate, length of stay and extra cost of sternal surgical site infections following coronary artery bypass grafting in a private medical centre in Turkey. J Hosp Infect. 2005;60:176–9.PubMedGoogle Scholar
  21. 21.
    Mugford M, Kingston J, Chalmers I. Reducing the incidence of infection after caesarean section: implications of prophylaxis with antibiotics for hospital resources. BMJ. 1989;299:1003–6.PubMedGoogle Scholar
  22. 22.
    Whitehouse JD, Friedman ND, Kirkland KB, Richardson WJ, Sexton DJ. The impact of surgical-site infections following orthopedic surgery at a community hospital and a university hospital: adverse quality of life, excess length of stay, and extra cost. Infect Control Hosp Epidemiol. 2002;23:183–9.PubMedGoogle Scholar
  23. 23.
    Scheckler WE. Hospital costs of nosocomial infections: a prospective three-month study in a community hospital. Infect Control. 1980;1:150–2.PubMedGoogle Scholar
  24. 24.
    Gavaldà L, Masuet C, Beltran J, Garcia M, Garcia D, Sirvent JM, et al. Comparative cost of selective screening to prevent transmission of methicillin-resistant Staphylococcus aureus (MRSA), compared with the attributable costs of MRSA infection. Infect Control Hosp Epidemiol. 2006;27:1264–6.PubMedGoogle Scholar
  25. 25.
    VandenBergh MF, Kluytmans JA, van Hout BA, Maat AP, Seerden RJ, McDonnel J, et al. Cost-effectiveness of perioperative mupirocin nasal ointment in cardiothoracic surgery. Infect Control Hosp Epidemiol. 1996;17:786–92.PubMedGoogle Scholar
  26. 26.
    Lynch W, Malek M, Davey PG, Byrne DJ, Napier A. Costing wound infection in a Scottish hospital. Pharmacoeconomics. 1992;2:163–70.PubMedGoogle Scholar
  27. 27.
    Reilly J, Twaddle S, McIntosh J, Kean L. An economic analysis of surgical wound infection. J Hosp Infect. 2001;49:245–9.PubMedGoogle Scholar
  28. 28.
    Kirkland KB, Briggs JP, Trivette SL, Wilkinson WE, Sexton DJ. The impact of surgical-site infections in the 1990s: attributable mortality, excess length of hospitalization, and extra costs. Infect Control Hosp Epidemiol. 1999;20:725–30.PubMedGoogle Scholar
  29. 29.
    Herwaldt LA, Cullen JJ, Scholz D, French P, Zimmerman MB, Pfaller MA, et al. A prospective study of outcomes, healthcare resource utilization, and costs associated with postoperative nosocomial infections. Infect Control Hosp Epidemiol. 2006;27:1291–8.PubMedGoogle Scholar
  30. 30.
    Hollenbeak CS, Murphy DM, Koenig S, Woodward RS, Dunagan WC, Fraser VJ. The clinical and economic impact of deep chest surgical site infections following coronary artery bypass graft surgery. Chest. 2000;118:397–402.PubMedGoogle Scholar
  31. 31.
    Vogel TR, Diaz JJ, Miller RS, May AK, Guillamondegui OD, Guy JS, et al. The open abdomen in trauma: do infectious complications affect primary abdominal closure? Surg Infect (Larchmt). 2006;7:433–41.Google Scholar
  32. 32.
    Kasatpibal N, Thongpiyapoom S, Narong MN, Suwalak N, Jamulitrat S. Extra charge and extra length of postoperative stay attributable to surgical site infection in six selected operations. J Med Assoc Thai. 2005;88:1083–91.PubMedGoogle Scholar
  33. 33.
    McGarry SA, Engemann JJ, Schmader K, Sexton DJ, Kaye KS. Surgical-site infection due to Staphylococcus aureus among elderly patients: mortality, duration of hospitalization, and cost. Infect Control Hosp Epidemiol. 2004;25:461–7.PubMedGoogle Scholar
  34. 34.
    Hollenbeak CS, Alfrey EJ, Sheridan K, Burger TL, Dillon PW. Surgical site infections following pediatric liver transplantation: risks and costs. Transpl Infect Dis. 2003;5:72–8.PubMedGoogle Scholar
  35. 35.
    Engemann JJ, Carmeli Y, Cosgrove SE, Fowler VG, Bronstein MZ, Trivette SL, et al. Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis. 2003;36:592–8.PubMedGoogle Scholar
  36. 36.
    Apisarnthanarak A, Jones M, Waterman BM, Carroll CM, Bernardi R, Fraser VJ. Risk factors for spinal surgical-site infections in a community hospital: a case–control study. Infect Control Hosp Epidemiol. 2003;24:31–6.PubMedGoogle Scholar
  37. 37.
    Hollenbeak CS, Murphy D, Dunagan WC, Fraser VJ. Nonrandom selection and the attributable cost of surgical-site infections. Infect Control Hosp Epidemiol. 2002;23:177–82.PubMedGoogle Scholar
  38. 38.
    Jenney AW, Harrington GA, Russo PL, Spelman DW. Cost of surgical site infections following coronary artery bypass surgery. ANZ J Surg. 2001;71:662–4.PubMedGoogle Scholar
  39. 39.
    Vegas AA, Jodra VM, García ML. Nosocomial infection in surgery wards: a controlled study of increased duration of hospital stays and direct cost of hospitalization. Eur J Epidemiol. 1993;9:504–10.PubMedGoogle Scholar
  40. 40.
    Laupland KB, Lee H, Gregson DB, Manns BJ. Cost of intensive care unit-acquired bloodstream infections. J Hosp Infect. 2006;63:124–32.PubMedGoogle Scholar
  41. 41.
    Blot SI, Depuydt P, Annemans L, Benoit D, Hoste E, De Waele JJ, et al. Clinical and economic outcomes in critically ill patients with nosocomial catheter-related bloodstream infections. Clin Infect Dis. 2005;41:1591–8.PubMedGoogle Scholar
  42. 42.
    Slonim AD, Kurtines HC, Sprague BM, Singh N. The costs associated with nosocomial bloodstream infections in the pediatric intensive care unit. Pediatr Crit Care Med. 2001;2:170–4.PubMedGoogle Scholar
  43. 43.
    Dimick JB, Pelz RK, Consunji R, Swoboda SM, Hendrix CW, Lipsett PA. Increased resource use associated with catheter-related bloodstream infection in the surgical intensive care unit. Arch Surg. 2001;136:229–34.PubMedGoogle Scholar
  44. 44.
    Elward AM, Hollenbeak CS, Warren DK, Fraser VJ. Attributable cost of nosocomial primary bloodstream infection in pediatric intensive care unit patients. Pediatrics. 2005;115:868–72.PubMedGoogle Scholar
  45. 45.
    Warren DK, Quadir WW, Hollenbeak CS, Elward AM, Cox MJ, Fraser VJ. Attributable cost of catheter-associated bloodstream infections among intensive care patients in a nonteaching hospital. Crit Care Med. 2006;34:2084–9.PubMedGoogle Scholar
  46. 46.
    Payne NR, Carpenter JH, Badger GJ, Horbar JD, Rogowski J. Marginal increase in cost and excess length of stay associated with nosocomial bloodstream infections in surviving very low birth weight infants. Pediatrics. 2004;114:348–55.PubMedGoogle Scholar
  47. 47.
    Orsi GB, Di Stefano L, Noah N. Hospital-acquired, laboratory-confirmed bloodstream infection: increased hospital stay and direct costs. Infect Control Hosp Epidemiol. 2002;23:190–7.PubMedGoogle Scholar
  48. 48.
    Digiovine B, Chenoweth C, Watts C, Higgins M. The attributable mortality and costs of primary nosocomial bloodstream infections in the intensive care unit. Am J Respir Crit Care Med. 1999;160:976–81.PubMedGoogle Scholar
  49. 49.
    Rosenthal VD, Guzman S, Migone O, Crnich CJ. The attributable cost, length of hospital stay, and mortality of central line-associated bloodstream infection in intensive care departments in Argentina: a prospective, matched analysis. Am J Infect Control. 2003;31:475–80.PubMedGoogle Scholar
  50. 50.
    Rello J, Ochagavia A, Sabanes E, Roque M, Mariscal D, Reynaga E, et al. Evaluation of outcome of intravenous catheter-related infections in critically ill patients. Am J Respir Crit Care Med. 2000;162:1027–30.PubMedGoogle Scholar
  51. 51.
    Wisplinghoff H, Cornely OA, Moser S, Bethe U, Stützer H, Salzberger B, et al. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case–control study. Infect Control Hosp Epidemiol. 2003;24:905–11.PubMedGoogle Scholar
  52. 52.
    Liu JW, Su YK, Liu CF, Chen JB. Nosocomial blood-stream infection in patients with end-stage renal disease: excess length of hospital stay, extra cost and attributable mortality. J Hosp Infect. 2002;50:224–7.PubMedGoogle Scholar
  53. 53.
    Abramson MA, Sexton DJ. Nosocomial methicillin-resistant and methicillin-susceptible Staphylococcus aureus primary bacteremia: at what costs? Infect Control Hosp Epidemiol. 1999;20:408–11.PubMedGoogle Scholar
  54. 54.
    Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271:1598–601.PubMedGoogle Scholar
  55. 55.
    Cocanour CS, Ostrosky-Zeichner L, Peninger M, Garbade D, Tidemann T, Domonoske BD, et al. Cost of a ventilator-associated pneumonia in a shock trauma intensive care unit. Surg Infect (Larchmt). 2005;6:65–72.Google Scholar
  56. 56.
    Hugonnet S, Eggimann P, Borst F, Maricot P, Chevrolet JC, Pittet D. Impact of ventilator-associated pneumonia on resource utilization and patient outcome. Infect Control Hosp Epidemiol. 2004;25:1090–6.PubMedGoogle Scholar
  57. 57.
    Warren DK, Shukla SJ, Olsen MA, Kollef MH, Hollenbeak CS, Cox MJ, et al. Outcome and attributable cost of ventilator-associated pneumonia among intensive care unit patients in a suburban medical center. Crit Care Med. 2003;31:1312–7.PubMedGoogle Scholar
  58. 58.
    van Nieuwenhoven CA, Buskens E, Bergmans DC, van Tiel FH, Ramsay G, Bonten MJ. Oral decontamination is cost-saving in the prevention of ventilator-associated pneumonia in intensive care units. Crit Care Med. 2004;32:126–30.PubMedGoogle Scholar
  59. 59.
    Dietrich ES, Demmler M, Schulgen G, Fekec K, Mast O, Pelz K, et al. Nosocomial pneumonia: a cost-of-illness analysis. Infection. 2002;30:61–7.PubMedGoogle Scholar
  60. 60.
    Rosenthal VD, Guzman S, Migone O, Safdar N. The attributable cost and length of hospital stay because of nosocomial pneumonia in intensive care units in 3 hospitals in Argentina: a prospective, matched analysis. Am J Infect Control. 2005;33:157–61.PubMedGoogle Scholar
  61. 61.
    Thompson DA, Makary MA, Dorman T, Pronovost PJ. Clinical and economic outcomes of hospital acquired pneumonia in intra-abdominal surgery patients. Ann Surg. 2006;243:547–52.PubMedGoogle Scholar
  62. 62.
    Merchant M, Karnad DR, Kanbur AA. Incidence of nosocomial pneumonia in a medical intensive care unit and general medical ward patients in a public hospital in Bombay, India. J Hosp Infect. 1998;39:143–8.PubMedGoogle Scholar
  63. 63.
    Kappstein I, Schulgen G, Beyer U, Geiger K, Schumacher M, Daschner FD. Prolongation of hospital stay and extra costs due to ventilator-associated pneumonia in an intensive care unit. Eur J Clin Microbiol Infect Dis. 1992;11:504–8.PubMedGoogle Scholar
  64. 64.
    Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol. 2002;23:27–31.PubMedGoogle Scholar
  65. 65.
    Lai KK, Fontecchio SA. Use of silver-hydrogel urinary catheters on the incidence of catheter-associated urinary tract infections in hospitalized patients. Am J Infect Control. 2002;30:221–5.PubMedGoogle Scholar
  66. 66.
    Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol. 1980;124:646–8.PubMedGoogle Scholar
  67. 67.
    Shulkin DJ, Kinosian B, Glick H, Glen-Puschett C, Daly J, Eisenberg JM. The economic impact of infections. An analysis of hospital costs and charges in surgical patients with cancer. Arch Surg. 1993;128:449–52.PubMedGoogle Scholar
  68. 68.
    Sheng WH, Wang JT, Lu DC, Chie WC, Chen YC, Chang SC. Comparative impact of hospital-acquired infections on medical costs, length of hospital stay and outcome between community hospitals and medical centres. J Hosp Infect. 2005;59:205–14.PubMedGoogle Scholar
  69. 69.
    Mahieu LM, Buitenweg N, Beutels P, De Dooy JJ. Additional hospital stay and charges due to hospital-acquired infections in a neonatal intensive care unit. J Hosp Infect. 2001;47:223–9.PubMedGoogle Scholar
  70. 70.
    Khan MM, Celik Y. Cost of nosocomial infection in Turkey: an estimate based on the university hospital data. Health Serv Manage Res. 2001;14:49–54.PubMedGoogle Scholar
  71. 71.
    Leroyer A, Bedu A, Lombrail P, Desplanques L, Diakite B, Bingen E, et al. Prolongation of hospital stay and extra costs due to hospital-acquired infection in a neonatal unit. J Hosp Infect. 1997;35:37–45.PubMedGoogle Scholar
  72. 72.
    Li LY, Wang SQ. Economic effects of nosocomial infections in cardiac surgery. J Hosp Infect. 1990;16:339–41.PubMedGoogle Scholar
  73. 73.
    Haley RW, Schaberg DR, Crossley KB, Von Allmen SD, McGowan JE Jr. Extra charges and prolongation of stay attributable to nosocomial infections: a prospective interhospital comparison. Am J Med. 1981;70:51–8.PubMedGoogle Scholar
  74. 74.
    Girard R, Fabry J, Meynet R, Lambert DC, Sepetjan M. Costs of nosocomial infection in a neonatal unit. J Hosp Infect. 1983;4:361–6.PubMedGoogle Scholar
  75. 75.
    Piednoir E, Bessaci K, Bureau-Chalot F, Sabouraud P, Brodard V, Andréoletti L, et al. Economic impact of healthcare-associated rotavirus infection in a paediatric hospital. J Hosp Infect. 2003;55:190–5.PubMedGoogle Scholar
  76. 76.
    Esatoğlu AE, Agirbas I, Onder OR, Celik Y. Additional cost of hospital-acquired infection to the patient: a case study in Turkey. Health Serv Manage Res. 2006;19:137–43.PubMedGoogle Scholar
  77. 77.
    Oncul O, Yüksel F, Altunay H, Açikel C, Celiköz B, Cavuşlu S. The evaluation of nosocomial infection during 1-year-period in the burn unit of a training hospital in Istanbul, Turkey. Burns. 2002;28:738–44.PubMedGoogle Scholar
  78. 78.
    Onen A, Ciğdem MK, Geyik MF, Kökoğlu OF, Otçu S, Oztürk H, et al. Epidemiology and control of nosocomial infections in paediatric surgery. J Hosp Infect. 2002;52:166–70.PubMedGoogle Scholar
  79. 79.
    Yalçin AN, Hayran M, Unal S. Economic analysis of nosocomial infections in a Turkish university hospital. J Chemother. 1997;9:411–4.PubMedGoogle Scholar
  80. 80.
    Wilcox MH, Cunniffe JG, Trundle C, Redpath C. Financial burden of hospital-acquired Clostridium difficile infection. J Hosp Infect. 1996;34:23–30.PubMedGoogle Scholar
  81. 81.
    de Clercq H, De Decker G, Alexander JP, Huyghens L. Cost evaluation of infections in intensive care. Acta Anaesthesiol Belg. 1983;34:179–89.PubMedGoogle Scholar
  82. 82.
    Wakefield DS, Helms CM, Massanari RM, Mori M, Pfaller M. Cost of nosocomial infection: relative contributions of laboratory, antibiotic, and per diem costs in serious Staphylococcus aureus infections. Am J Infect Control. 1988;16:185–92.PubMedGoogle Scholar
  83. 83.
    Chen YY, Chou YC, Chou P. Impact of nosocomial infection on cost of illness and length of stay in intensive care units. Infect Control Hosp Epidemiol. 2005;26:281–7.PubMedGoogle Scholar
  84. 84.
    Roberts RR, Scott RD 2nd, Cordell R, Solomon SL, Steele L, Kampe LM, et al. The use of economic modeling to determine the hospital costs associated with nosocomial infections. Clin Infect Dis. 2003;36:1424–32.PubMedGoogle Scholar
  85. 85.
    Noskin GA, Rubin RJ, Schentag JJ, Kluytmans J, Hedblom EC, Smulders M, et al. The burden of Staphylococcus aureus infections on hospitals in the United States: an analysis of the 2000 and 2001 Nationwide Inpatient Sample Database. Arch Intern Med. 2005;165:1756–61.PubMedGoogle Scholar
  86. 86.
    Song X, Srinivasan A, Plaut D, Perl TM. Effect of nosocomial vancomycin-resistant enterococcal bacteremia on mortality, length of stay, and costs. Infect Control Hosp Epidemiol. 2003;24:251–6.PubMedGoogle Scholar
  87. 87.
    Gray JE, Richardson DK, McCormick MC, Goldmann DA. Coagulase-negative staphylococcal bacteremia among very low birth weight infants: relation to admission illness severity, resource use, and outcome. Pediatrics. 1995;95:225–30.PubMedGoogle Scholar
  88. 88.
    Upton A, Smith P, Roberts S. Excess cost associated with Staphylococcus aureus poststernotomy mediastinitis. N Z Med J. 2005;118:U1316.PubMedGoogle Scholar
  89. 89.
    Lazarus HM, Fox J, Burke JP, Lloyd JF, Snow GL, Mehta RR, et al. Trauma patient hospital-associated infections: risks and outcomes. J Trauma. 2005;59:188–94.PubMedGoogle Scholar
  90. 90.
    Dominguez TE, Chalom R, Costarino AT Jr. The impact of adverse patient occurrences on hospital costs in the pediatric intensive care unit. Crit Care Med. 2001;29:169–74.PubMedGoogle Scholar
  91. 91.
    Macartney KK, Gorelick MH, Manning ML, Hodinka RL, Bell LM. Nosocomial respiratory syncytial virus infections: the cost-effectiveness and cost-benefit of infection control. Pediatrics. 2000;106:520–6.PubMedGoogle Scholar
  92. 92.
    Nelson RM, Dries DJ. The economic implications of infection in cardiac surgery. Ann Thorac Surg. 1986;42:240–6.PubMedGoogle Scholar
  93. 93.
    Pirson M, Dramaix M, Struelens M, Riley TV, Leclercq P. Costs associated with hospital-acquired bacteraemia in a Belgian hospital. J Hosp Infect. 2005;59:33–40.PubMedGoogle Scholar
  94. 94.
    Watters K, O’Dwyer TP, Rowley H. Cost and morbidity of MRSA in head and neck cancer patients: what are the consequences? J Laryngol Otol. 2004;118:694–9.PubMedGoogle Scholar
  95. 95.
    Taylor GJ, Mikell FL, Moses HW, Dove JT, Katholi RE, Malik SA, et al. Determinants of hospital charges for coronary artery bypass surgery: the economic consequences of postoperative complications. Am J Cardiol. 1990;65:309–13.PubMedGoogle Scholar
  96. 96.
    Zhan C, Miller MR. Excess length of stay, charges, and mortality attributable to medical injuries during hospitalization. JAMA. 2003;290:1868–74.PubMedGoogle Scholar
  97. 97.
    Haley RW, Schaberg DR, Von Allmen SD, McGowan JE Jr. Estimating the extra charges and prolongation of hospitalization due to nosocomial infections: a comparison of methods. J Infect Dis. 1980;141:248–57.PubMedGoogle Scholar
  98. 98.
    Sánchez-Velázquez LD, Ponce de León Rosales S, Rangel Frausto MS. The burden of nosocomial infection in the intensive care unit: effects on organ failure, mortality and costs. A nested case–control study. Arch Med Res. 2006;37:370–5.PubMedGoogle Scholar
  99. 99.
    Chaix C, Durand-Zaleski I, Alberti C, Brun-Buisson C. Control of endemic methicillin-resistant Staphylococcus aureus: a cost–benefit analysis in an intensive care unit. JAMA. 1999;282:1745–51.PubMedGoogle Scholar
  100. 100.
    Orrett FA, Brooks PJ, Richardson EG. Nosocomial infections in a rural regional hospital in a developing country: infection rates by site, service, cost, and infection control practices. Infect Control Hosp Epidemiol. 1998;19:136–40.PubMedGoogle Scholar
  101. 101.
    O’Brien BJ. A tale of two (or more) cities: geographic transferability of pharmacoeconomic data. Am J Manag Care. 1997;3:S33–9.PubMedGoogle Scholar
  102. 102.
    Wennberg JE, Barnes BA, Zubkoff M. Professional uncertainty and the problem of supplier-induced demand. Soc Sci Med. 1982;16:811–24.PubMedGoogle Scholar
  103. 103.
    Jefferson T, Demicheli V, Vale L. Quality of systematic reviews of economic evaluations in health care. JAMA. 2002;287:2809–12.PubMedGoogle Scholar
  104. 104.
    Howard D, Cordell R, McGowan JE Jr, Packard RM, Scott RD 2nd, Solomon SL. Measuring the economic costs of antimicrobial resistance in hospital settings: summary of the Centers for Disease Control and Prevention-Emory Workshop. Clin Infect Dis. 2001;33:1573–8.PubMedGoogle Scholar
  105. 105.
    Finkler SA. The distinction between cost and charges. Ann Intern Med. 1982;96:102–9.PubMedGoogle Scholar
  106. 106.
    Stone PW, Larson E, Kawar LN. A systematic audit of economic evidence linking nosocomial infections and infection control interventions: 1990–2000. Am J Infect Control. 2002;30:145–52.PubMedGoogle Scholar
  107. 107.
    Sassi F, Archard L, McDaid D. Searching literature databases for health care economic evaluations: how systematic can we afford to be? Med Care. 2002;40:387–94.PubMedGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  1. 1.Institute for Health Economics and PolicyTokyoJapan
  2. 2.Department of Healthcare Economics and Quality Management, School of Public Health, Graduate School of MedicineKyoto UniversityKyotoJapan

Personalised recommendations